Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Search Product Recalls

Try:····

Filters

Time Period

All Time Last 30 Days Last 90 Days Last Year

State

Showing 5621–5640 of 15081 results

Sort:

Newest first Oldest first

Daratumumab Infusion (Infusion Options) – Sterility Risk (2019)

Lack of Assurance of Sterility

Class IIModerate

FDAJun 12, 2019NY• Infusion Options, Inc.

Pertuzumab Infusion (Infusion Options) – Sterility Risk (2019)

Lack of Assurance of Sterility

Class IIModerate

FDAJun 12, 2019NY• Infusion Options, Inc.

Ondansetron Infusion (Infusion Options) – Sterility Risk (2019)

Lack of Assurance of Sterility

Class IIModerate

FDAJun 12, 2019NY• Infusion Options, Inc.

Mitomycin Syringe (Infusion Options) – Sterility Risk (2019)

Lack of Assurance of Sterility

Class IIModerate

FDAJun 12, 2019NY• Infusion Options, Inc.

Bleomycin Infusion (Infusion Options) – Sterility Risk (2019)

Lack of Assurance of Sterility

Class IIModerate

FDAJun 12, 2019NY• Infusion Options, Inc.

Nivolumab IV Solution (Infusion Options) – Sterility Concern (2019)

Lack of Assurance of Sterility

Class IIModerate

FDAJun 12, 2019NY• Infusion Options, Inc.

Rituximab IV Solution (Infusion Options) – Sterility Concern (2019)

Lack of Assurance of Sterility

Class IIModerate

FDAJun 12, 2019NY• Infusion Options, Inc.

Darzalex IV Solution (Infusion Options) – Sterility Concern (2019)

Lack of Assurance of Sterility

Class IIModerate

FDAJun 12, 2019NY• Infusion Options, Inc.

Carboplatin IV Solution (Infusion Options) – Sterility Concern (2019)

Lack of Assurance of Sterility

Class IIModerate

FDAJun 12, 2019NY• Infusion Options, Inc.

Eribulin IV Solution (Infusion Options) – Sterility Concern (2019)

Lack of Assurance of Sterility

Class IIModerate

FDAJun 12, 2019NY• Infusion Options, Inc.

Adcetris 96 MG (Infusion Options) – Sterility Concern (2019)

Lack of Assurance of Sterility

Class IIModerate

FDAJun 12, 2019NY• Infusion Options, Inc.

Cetuximab IV Solution (Infusion Options) – Sterility Concern (2019)

Lack of Assurance of Sterility

Class IIModerate

FDAJun 12, 2019NY• Infusion Options, Inc.

Atezolizumab (Infusion Options) – Sterility Concern (2019)

Lack of Assurance of Sterility

Class IIModerate

FDAJun 12, 2019NY• Infusion Options, Inc.

Iron Sucrose Infusion (Infusion Options) – Sterility Risk (2019)

Lack of Assurance of Sterility

Class IIModerate

FDAJun 12, 2019NY• Infusion Options, Inc.

RomiPLOStim Syringe (Infusion Options) – Sterility Concern (2019)

Lack of Assurance of Sterility

Class IIModerate

FDAJun 12, 2019NY• Infusion Options, Inc.

Orencia IV Solution (Infusion Options) – Sterility Concern (2019)

Lack of Assurance of Sterility

Class IIModerate

FDAJun 12, 2019NY• Infusion Options, Inc.

Carfilzomib (Infusion Options) – Sterility Concern (2019)

Lack of Assurance of Sterility

Class IIModerate

FDAJun 12, 2019NY• Infusion Options, Inc.

Pembrolizumab IV Solution (Infusion Options) – Sterility Concern (2019)

Lack of Assurance of Sterility

Class IIModerate

FDAJun 12, 2019NY• Infusion Options, Inc.

Testosterone Topical Solution (InvaGen) – Defective Container (2019)

Defective Container; actuator may improperly function and affect dose delivery.

Class IIILow

FDAJun 12, 2019Nationwide• InvaGen Pharmaceuticals, Inc.

Granisetron (Infusion Options) – Sterility Concern (2019)

Lack of Assurance of Sterility

Class IIModerate

FDAJun 12, 2019NY• Infusion Options, Inc.

1...280 281282283 284...755

Page 282 of 755Next